ANGIODYNAMICS INC — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| GOLD JEFFREY | — | Purchase | 1,000 | $10.56 | $10,560 | 25,233 | Nov 5, 2012 |
| SOTO JOHN | SVP - Global Franchise Leader | Award / Grant | 10,000 | — | — | 10,000 | Oct 23, 2012 |
| DEVIVO JOSEPH | President and CEO | Tax Withholding | 2,526 | $12.12 | $30,615 | 60,571 | Sep 7, 2012 |
| GERSUK D JOSEPH | EVP - CFO | Tax Withholding | 1,086 | $11.61 | $12,608 | 47,275 | Sep 4, 2012 |
| Richard Stark | SVP, GM - Oncology | Tax Withholding | 715 | $11.61 | $8,301 | 29,091 | Sep 4, 2012 |
| Etlinger Richard Scott | SVP - Global Operations | Tax Withholding | 543 | $10.70 | $5,810 | 5,457 | Aug 23, 2012 |
| PANZER ALAN | SVP, GM - Vascular | Award / Grant | 7,500 | — | — | 27,500 | Aug 17, 2012 |
| Kapusta Matthew C | SVP, Business Development | Award / Grant | 5,000 | — | — | 21,000 | Aug 17, 2012 |
| DEVIVO JOSEPH | President and CEO | Award / Grant | 22,247 | — | — | 63,097 | Aug 17, 2012 |
| Richard Stark | SVP, GM - Oncology | Award / Grant | 10,000 | — | — | 29,806 | Aug 17, 2012 |
| Etlinger Richard Scott | SVP - Global Operations | Award / Grant | 6,500 | — | — | 11,957 | Aug 17, 2012 |
| McGill Stephen | SVP, GM - International | Award / Grant | 15,000 | — | — | 21,986 | Aug 17, 2012 |
| GERSUK D JOSEPH | EVP - CFO | Award / Grant | 12,000 | — | — | 48,361 | Aug 17, 2012 |
| BUCCI VINCENT | — | Award / Grant | 2,850 | — | — | 36,696 | Aug 7, 2012 |
| JOHNSON WESLEY | — | Award / Grant | 2,850 | — | — | 10,850 | Aug 7, 2012 |
| GOLD JEFFREY | — | Award / Grant | 2,850 | — | — | 24,233 | Aug 7, 2012 |
| DONNELLY HOWARD W | — | Award / Grant | 2,850 | — | — | 12,850 | Aug 7, 2012 |
| Meteny Dennis S | — | Award / Grant | 2,850 | — | — | 17,350 | Aug 7, 2012 |
| DEVIVO JOSEPH | President and CEO | Award / Grant | 2,850 | — | — | 40,850 | Aug 7, 2012 |
| Gould Kevin J | — | Award / Grant | 2,850 | — | — | 5,550 | Aug 7, 2012 |
| LaPorte Steve | — | Award / Grant | 2,850 | — | — | 10,863 | Aug 7, 2012 |
| Burgstahler David F | — | Award / Grant | 2,850 | — | — | 2,850 | Aug 7, 2012 |
| McGill Stephen | SVP, GM - International | Tax Withholding | 367 | $10.70 | $3,927 | 7,616 | Aug 3, 2012 |
| GERSUK D JOSEPH | EVP - CFO | Tax Withholding | 1,358 | $10.70 | $14,531 | 37,175 | Aug 3, 2012 |
| Richard Stark | SVP, GM - Oncology | Tax Withholding | 759 | $10.70 | $8,121 | 19,806 | Aug 3, 2012 |
| DEVIVO JOSEPH | President and CEO | Purchase | 2,000 | $11.67 | $23,340 | 38,000 | Jul 17, 2012 |
| Bourne George W. IV | SVP and CTO | Award / Grant | 10,000 | — | — | 10,000 | May 21, 2012 |
| Richard Stark | SVP, GM - Oncology | Sale | 2,080 | $12.42 | $25,834 | 20,922 | May 16, 2012 |
| GOLD JEFFREY | — | Option Exercise | 418 | $6.52 | $2,725 | 21,383 | Apr 25, 2012 |
| ECHENBERG PAUL S | — | Option Exercise | 2,091 | $6.52 | $13,633 | 154,412 | Apr 23, 2012 |
| BUCCI VINCENT | — | Purchase | 4,000 | $11.82 | $47,280 | 4,000 | Apr 12, 2012 |
| BUCCI VINCENT | — | Purchase | 2,000 | $11.87 | $23,740 | 33,846 | Apr 12, 2012 |
| Gould Kevin J | — | Purchase | 2,700 | $11.72 | $31,644 | 2,700 | Apr 11, 2012 |
| Kapusta Matthew C | SVP, Business Development | Purchase | 1,000 | $11.40 | $11,400 | 16,000 | Apr 10, 2012 |
| BUCCI VINCENT | — | Purchase | 2,000 | $11.80 | $23,600 | 31,846 | Apr 9, 2012 |
| DEVIVO JOSEPH | President and CEO | Purchase | 5,000 | $11.82 | $59,100 | 36,000 | Apr 9, 2012 |
| BUCCI VINCENT | — | Purchase | 2,000 | $13.44 | $26,880 | 29,846 | Feb 21, 2012 |
| DEVIVO JOSEPH | President and CEO | Purchase | 3,000 | $12.95 | $38,850 | 31,000 | Feb 13, 2012 |
| BUCCI VINCENT | — | Purchase | 2,000 | $13.25 | $26,500 | 27,846 | Feb 13, 2012 |
| Kapusta Matthew C | SVP, Business Development | Award / Grant | 15,000 | — | — | 15,000 | Feb 2, 2012 |
| DEVIVO JOSEPH | President and CEO | Purchase | 2,500 | $14.15 | $35,375 | 28,000 | Nov 16, 2011 |
| PANZER ALAN | SVP, GM - Vascular | Award / Grant | 20,000 | — | — | 20,000 | Oct 18, 2011 |
| DEVIVO JOSEPH | President and CEO | Award / Grant | 25,000 | — | — | 25,000 | Sep 7, 2011 |
| GERSUK D JOSEPH | EVP - CFO | Option Exercise | 3,000 | $13.49 | $40,470 | 39,619 | Sep 6, 2011 |
| Meteny Dennis S | — | Option Exercise | 5,000 | $11.00 | $55,000 | 14,500 | Aug 31, 2011 |
| BUCCI VINCENT | — | Purchase | 2,700 | $14.01 | $37,827 | 3,000 | Aug 16, 2011 |
| McGill Stephen | SVP, GM - International | Tax Withholding | 367 | $13.53 | $4,966 | 7,983 | Aug 3, 2011 |
| Etlinger Richard Scott | SVP - Global Operations | Award / Grant | 6,000 | — | — | 6,000 | Aug 3, 2011 |
| GERSUK D JOSEPH | EVP - CFO | Tax Withholding | 1,358 | $13.53 | $18,374 | 36,619 | Aug 3, 2011 |
| Solano Scott J. | Interim CEO | Tax Withholding | 1,672 | $13.53 | $22,622 | 8,945 | Aug 3, 2011 |